TFA Therapeutics, Inc. (RAJAF): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$37.2K
Year ended 2024-12-31
$40.2K2021-12-31: -$465.4K2022-12-31: -$321.9K2023-12-31: $40.2K2024-12-31: -$37.2K-$37.2K
2021-12-31 Free Cash Flow (USD) 2024-12-31
Period endedFree Cash FlowChange YoYSource filing
2024-12-31-$37.2Kn/m2026-05-15, From 2024-01-01
2023-12-31$40.2Kn/m2026-05-15, From 2023-01-01
2022-12-31-$321.9Kn/c2025-09-23, From 2022-01-01
2021-12-31-$465.4Kn/a2025-09-23, From 2021-01-01